CeriBell (CBLL) vs EDAP TMS S.A. (FOCL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
EDAP TMS S.A. (FOCL) has outperformed CeriBell (CBLL) over the past year, gaining 93.1% versus a gain of 84.3%. CeriBell is the larger company by market cap ($906.9 million vs $197.8 million), about 4.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBLL | FOCL |
|---|---|---|
| Share price | $23.63 | $4.19 |
| Market cap | $906.87M | $197.84M |
| 1-day change | +2.07% | +1.58% |
| YTD return | +7.75% | +27.36% |
| 1-year return | +84.32% | +93.09% |
| 5-year return | — | -30.74% |
| EPS (TTM) | $-1.76 | $-1.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.63 | $6.40 |
| 52-week low | $10.85 | $1.75 |
| Distance from 52-week high | -7.79% | -34.53% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +20.91% | +110.02% |
| Average volume | 370.29K | 114.80K |
| Shares outstanding | 38.38M | 47.22M |
| Employees | 327 | 289 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CeriBell is about 4.6 times larger than EDAP TMS S.A. by market value ($906.87M vs $197.84M).
About CeriBell
CBLL stock →CeriBell, Inc. operates as a medical technology company in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 327 employees
About EDAP TMS S.A.
FOCL stock →EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 289 employees
CBLL vs FOCL FAQ
Which is bigger, CeriBell or EDAP TMS S.A.?
CeriBell (CBLL) is larger, with a market capitalization of $906.87M compared with $197.84M for EDAP TMS S.A. (FOCL).
Which stock has performed better over the past year, CBLL or FOCL?
FOCL returned +93.09% over the past 12 months, compared with +84.32% for CBLL (price return, excluding dividends). Past performance does not predict future results.
Are CeriBell and EDAP TMS S.A. in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.